Impact News +++ NIO-SW Shares Slump 11% in Afternoon; Aug Deliveries Rise 14.5% YoY (AAStocks) +++ NIO ADR Aktie -7,90%

LABCORP Aktie

>LABCORP Aktienkurs

294 EUR +2.1% (TradegateBSX)

Ask: 294 EUR / 21 Stück

Bid: 288 EUR / 22 Stück

Tagesumsatz: 35 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

LABCORP Aktie über LYNX handeln

Intraday

1 Jahr

>LABCORP Performance

1 Woche: +2,8%

1 Monat: +8,6%

3 Monate: +30,9%

6 Monate: +19,2%

1 Jahr: +23,2%

laufendes Jahr: +36,4%

>LABCORP Aktie

Profil:

Labcorp Holdings Inc. is a healthcare diagnostics and laboratory services company that supports physicians, hospitals, pharmaceutical companies, researchers, and patients with clinical testing and scientific insights. Labcorp Holdings Inc. operates t..
>Volltext..

Insiderhandel:

>LABCORP Kennzahlen

Aktien/ Unternehmen:

Analysten:

Bewertung:

Rentabilität:

Managementeffizenz:

>LABCORP Peer Group

Gesundheit, Onkologie/ Krebs- Behandlung

>LABCORP Chart & Kurs - NYSE

>LABCORP News

31.08.26 - 19:30	Living Security: Human Risk Management Leaders from Reveal Risk, Bayer, and Labcorp to Speak at HRMCon 2026 (Accesswire)
	Enterprise CISOs and cybersecurity leaders will share real-world lessons for strengthening Workforce Security, advancing Security Behavior Management, and reducing risk across humans and AI agents ......

31.08.26 - 13:03	Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity (PR Newswire)
	Enhanced digital experience designed to improve visibility, simplify workflows and support faster decision-making BURLINGTON, N.C., Aug. 31, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory solutions, today announced enhancements to the......

28.08.26 - 14:33	Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference (PR Newswire)
	BURLINGTON, N.C., Aug. 28, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare......

28.08.26 - 00:03	XETR: DIVIDEND/INTEREST INFORMATION - 28.08.2026 - US5049221055 (XETRA)
	Das Instrument N6B US5049221055 LABCORP HLDGS INC. O.N. EQUITY wird ex Dividende/Zinsen gehandelt am 28.08.2026 The instrument N6B US5049221055 LABCORP HLDGS INC. O.N. EQUITY has its ex-dividend/interest day on 28.08.2026...

26.08.26 - 23:57	XETR: DIVIDEND/INTEREST INFORMATION - 28.08.2026 - US5049221055 (XETRA)
	Das Instrument N6B US5049221055 LABCORP HLDGS INC. O.N. EQUITY wird cum Dividende/Zinsen gehandelt am 27.08.2026 und ex Dividende/Zinsen am 28.08.2026 The instrument N6B US5049221055 LABCORP HLDGS INC. O.N. EQUITY has its pre-dividend/interest day on 27.08.2026 and its ex-dividend/interest day on 28.08.2026...

25.08.26 - 16:45	Should You Continue to Hold Labcorp Stock in Your Portfolio? (Zacks)
	LH's specialty-testing expansion, strategic partnerships and buybacks support growth, while reimbursement and cost pressures pose risks....

24.08.26 - 13:06	Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer′s Disease Pathology in Both Primary and Specialty Care Settings (PR Newswire)
	Elecsys® pTau-217 is the first and only FDA-cleared single-biomarker blood test to both rule in and rule out amyloid pathology across specialty and primary care settings Measures phosphorylated Tau 217 (pTau-217), an indicator of amyloid pathology and a hallmark of Alzheimer's disease......

18.08.26 - 16:02	Insiderhandel: Aufsichtsrat verkauft Aktien von Laboratory im Wert von 954060 USD (Insiderkauf)
	Anderson, Kerrii B. - Aufsichtsrat - Tag der Transaktion: 2026-08-17...

18.08.26 - 13:03	Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health (PR Newswire)
	Collaboration will support leadership development, practice improvement and innovation across the nation's Community Health Centers BURLINGTON, N.C. and BETHESDA, Md., Aug. 18, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services,......

17.08.26 - 14:06	Labcorp to Host Investor Day on September 10, 2026 (PR Newswire)
	BURLINGTON, N.C., Aug. 17, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced it will host an Investor Day on Thursday, September 10, 2026, from 9 a.m. to noon ET. Chairman and CEO Adam Schechter,......

13.08.26 - 01:01	Insiderhandel: President & CEO verkauft Aktien von Laboratory im Wert von 1495808 USD (Insiderkauf)
	Schechter, Adam H. - Vorstand - Tag der Transaktion: 2026-08-11...

12.08.26 - 23:48	Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million (Fool)
	Schechter maintains a $33 million stake after this pre-scheduled sale under a Rule 10b5-1 plan....

10.08.26 - 18:15	Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich? (Zacks)
	LH enters late 2026 with stronger growth, margin gains and raised guidance, but a rich valuation and cost risks support a measured view....

10.08.26 - 17:30	Here′s Why Labcorp Holdings (LH) is a Strong Momentum Stock (Zacks)
	Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....

10.08.26 - 13:36	Labcorp Announces FDA Approval Of PGDx Elio Tissue Complete CDx (AFX)
	WASHINGTON (dpa-AFX) - Labcorp (LH) announced the FDA has approved PGDx elio tissue complete CDx as a companion diagnostic to help identify patients with advanced melanoma with certain BRAF varian......

10.08.26 - 13:03	Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma (PR Newswire)
	Labcorp's FDA‑approved PGDx elio® tissue complete CDx helps identify advanced melanoma patients with certain BRAF variants eligible for BRAF and BRAF/MEK inhibitor therapies Supports access to targeted treatment options for the deadliest form of skin cancer BURLINGTON, N.C., Aug. 10, 2026......

07.08.26 - 18:15	Labcorp Stock Jumps 14% in a Month as Growth Meets Rich Valuation (Zacks)
	LH shares surged 14% in a month as stronger earnings, margin gains and growth collide with a valuation above the company's five-year median....

06.08.26 - 17:01	Insiderhandel: EVP, Chief Marketing Officer verkauft Aktien von Laboratory im Wert von 283428 USD (Insiderkauf)
	Summy, Amy B. - Vorstand - Tag der Transaktion: 2026-08-04...

05.08.26 - 20:02	Insiderhandel: SVP, Chief Accounting Officer verkauft Aktien von Laboratory im Wert von 439107 USD (Insiderkauf)
	Wilkinson, Peter J. - Vorstand - Tag der Transaktion: 2026-08-03...

04.08.26 - 13:01	Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer (PR Newswire)
	First FDA-approved IHC assay identifies patients who may be eligible for combination treatment with TRUQAP® (capivasertib) BURLINGTON, N.C., Aug. 4, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the nationwide......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Dem Schöpfer eines guten Satzes kommt der am nächsten, der den Satz zuerst zitiert. - Ralph Waldo Emerson

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram